(BX4) Lyxor CAC 40 Daily Double - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: FR0010411884

Leveraged, Inverse, Equity, Shares, Daily, Returns, France

Description: BX4 Lyxor CAC 40 Daily Double

The Lyxor UCITS CAC40 Daily Double Short (PA:BX4) is an ETF designed to provide double the inverse daily return of the CAC 40 index, a benchmark for the French stock market. This means that if the CAC 40 index falls by 1%, the ETF is expected to rise by 2%, before fees and expenses.

Analyzing the ETFs characteristics, we can infer that it is designed for traders and investors who are bearish on the French stock market or looking to hedge their long positions in the CAC 40 index. The ETFs double short exposure makes it a speculative investment, suitable for those who are willing to take on higher risks in pursuit of potentially higher returns.

Examining the ETFs , we can observe that the last price is 0.73, which is below its 20-day, 50-day, and 200-day Simple Moving Averages (SMA). This suggests that the ETF has been trending downwards in the short to long term. However, the Average True Range (ATR) is 0.04, indicating a relatively high volatility of 5.13%. This volatility, combined with the ETFs double short exposure, may result in significant losses if the CAC 40 index rises.

Using the available and , we can forecast the ETFs potential performance. If the CAC 40 index experiences a significant decline, the ETF is likely to benefit from its double short exposure. Conversely, if the index rises, the ETFs value will likely decrease. Given the current AUM of 215.26M EUR, the ETF has a moderate level of liquidity, which may help mitigate potential losses due to trading activity.

Based on the available data, a potential trading strategy could involve closely monitoring the CAC 40 index and adjusting positions accordingly. If the index is expected to decline, taking a long position in the Lyxor UCITS CAC40 Daily Double Short ETF could be considered. However, if the index is expected to rise, it may be prudent to avoid or short the ETF. A more detailed analysis of market trends, economic indicators, and other factors influencing the CAC 40 index would be necessary to make a more informed investment decision.

Additional Sources for BX4 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BX4 ETF Overview

Market Cap in USD 253m
Category Trading - Leveraged/Inverse Equity
TER 0.60%
IPO / Inception 2007-01-15

BX4 ETF Ratings

Growth Rating -81.2
Fundamental -
Dividend Rating 0.0
Rel. Strength -23.9
Analysts -
Fair Price Momentum 0.56 EUR
Fair Price DCF -

BX4 Dividends

Currently no dividends paid

BX4 Growth Ratios

Growth Correlation 3m -44.2%
Growth Correlation 12m -56.7%
Growth Correlation 5y -93.9%
CAGR 5y -24.68%
CAGR/Max DD 5y -0.31
Sharpe Ratio 12m -1.60
Alpha -7.80
Beta -1.083
Volatility 23.08%
Current Volume 8444.4k
Average Volume 20d 6418k
Stop Loss 0.7 (-1.4%)
What is the price of BX4 shares?
As of July 12, 2025, the stock is trading at EUR 0.71 with a total of 8,444,381 shares traded.
Over the past week, the price has changed by -3.62%, over one month by -2.76%, over three months by -22.39% and over the past year by -13.00%.
Is Lyxor CAC 40 Daily Double a good stock to buy?
No, based on ValueRay´s Analyses, Lyxor CAC 40 Daily Double (PA:BX4) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -81.23 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BX4 is around 0.56 EUR . This means that BX4 is currently overvalued and has a potential downside of -21.13%.
Is BX4 a buy, sell or hold?
Lyxor CAC 40 Daily Double has no consensus analysts rating.
What are the forecasts for BX4 share price target?
According to our own proprietary Forecast Model, BX4 Lyxor CAC 40 Daily Double will be worth about 0.6 in July 2026. The stock is currently trading at 0.71. This means that the stock has a potential downside of -14.08%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 0.6 -14.1%